Analysis of 35 commercial dietary supplements of Goldenseal (Hydrastis canadensis L.) showed that only three did not contain what they claimed to contain. Goldenseal adulteration is well documented, and one expert says it's difficult to believe that...
A new study has found that supplements marketed for weight loss and sports applications that contain the ingredient higenamine had widely varying and unpredictable dosages of this stimulant.
Instead of relying on a ‘precautionary zero tolerance’ for pesticide residue in dietary supplements, NSF International updated the maximum allowable level for companies to pass its quality test.
HerbalGram has grown into one of the world’s most influential herbal medicine journals as it celebrates its 35th anniversary. Founder Mark Blumenthal says he’s certain he made the right decision almost 30 years ago to give the publication away.
The botanical Boswellia has been used for its anti-inflammatory properties for millennia, but it’s not uncommon to find some products today labeled as Boswellia to skimp on the amount of the botanical or to substitute in a less-researched form.
The latest Botanical Adulterants Bulletin focuses on the top-selling dietary supplement in US natural food stores: turmeric (Curcuma longa) rhizome and its extracts.
Valensa International has fixed on a certification from the Florida Department of Agriculture as a way to highlight the special properties of saw palmetto and the quality issues that surround the botanical.
The Center for Science in the Public Interest has warned consumers to avoid ginkgo products and called for FDA enforcement because of what it characterized as widespread adulteration.
LabCorp announced today that it has entered a definitive agreement to sell its Covance Food Solutions business to Eurofins Scientific for $670 million.
A bill to give DEA more authority to get SARMs off the market has been introduced by longtime dietary supplement industry supporter Sen. Orrin Hatch, R-UT.
Another dietary supplement manufacturer has been shut down by FDA, in this case for including illicit active pharmaceutical ingredients in its products.
FDA is stepping up monitoring illegal products entering the country, according to a blog post from Commissioner Scott Gottlieb. The development was welcomed by industry stakeholders, assuming it is more than mere window dressing.
